September 19, 2013


"Shares of Kythera Biopharmaceuticals surged Tuesday after the company said a drug intended to treat double chins met its goals in two late-stage clinical studies."

Really? People are dying of cancer and heart disease daily, but the dedicated scientists at Kythera Biopharmaceuticals have figured out a way to get rid of chin fat. Jeez.

No comments: